scholarly article | Q13442814 |
P356 | DOI | 10.1097/00008571-199206000-00004 |
P953 | full work available at URL | https://journals.lww.com/00008571-199206000-00004 |
P698 | PubMed publication ID | 1306112 |
P2093 | author name string | P. Smith | |
R. A. Branch | |||
G. R. Wilkinson | |||
C. M. Fleming | |||
A. Kaisary | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | genetics | Q7162 |
bladder cancer | Q504775 | ||
P304 | page(s) | 128-134 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | Pharmacogenetics and Genomics | Q10534561 |
P1476 | title | The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer | |
P478 | volume | 2 |
Q36832297 | Epidemiology of urinary bladder cancer: from tumor development to patient's death |
Q38855185 | The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer. |
Q73846452 | Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes |
Search more.